Skip to main content
padlock icon - secure page this page is secure

Open Access Where do Personalized Health Technologies stand today?

Download Article:
 Download
(PDF 237.2 kb)
 
In June 2018, experts met at ETH Zurich to discuss technological challenges in advanced cell systems, variant interpretation, novel therapeutics and the integration of clinical data. The translation of these technologies into innovative clinical approaches in oncology, immunology, infectious diseases, neurology and cardiology will be a challenge for the future. Detailed information at http://www.personalizedhealth.nexus.ethz.ch/
No References for this article.
No Supplementary Data.
No Article Media
No Metrics

Keywords: CANCER PRECISION MEDICINE PROGRAM; CAR T CELLS; DATA + COMPUTING SERVICES; IMMUNOTHERAPY; METASTATIC LUNG CANCER; MULTIPLE SCLEROSIS CARE; PROSTATE CANCER

Document Type: Regular Paper

Publication date: September 1, 2018

More about this publication?
  • International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions

    CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Information for Advertisers
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more